Baker McKenzie advises Mitsui Chemicals on its acquisition of Ultradent Products, Inc.
Baker & McKenzie (Gaikokuho Joint Enterprise) (“Baker McKenzie”) has advised Mitsui Chemicals, Inc. (“Mitsui Chemicals”) on its acquisition of US-based Ultradent Products, Inc. (“Ultradent”).
Mitsui Chemicals is a global comprehensive chemical manufacturer based in Japan. Ultradent is a US-based manufacturer of dental materials and a global leader in teeth whitening and dental restorative products, with a strong sales network in North America. The acquisition of Ultradent is expected to enhance Mitsui Chemicals’ presence in life and healthcare solutions — a key specialty chemical domain in which the company has been actively expanding its business through M&A and strategic partnerships.
In this transaction, Mitsui Chemicals America, Inc. (“MCA”), a US-based subsidiary of Mitsui Chemicals, will acquire the shares and business assets of Ultradent through a newly established holding company, thereby making Ultradent a wholly owned subsidiary. The total transaction value is approximately USD 900 million, subject to customary adjustments, and is expected to be completed in September 2026 subject to the satisfaction of customary closing conditions, including regulatory approval under the applicable competition laws.
Baker McKenzie provided comprehensive legal support on this cross-border transaction. The project was led by Tokyo Corporate/M&A Partner Kiyoshi Endo with support from Partner Seiji Tomimoto and Associates Ayaka Iwamoto, Soichiro Goto, Naruhiko Yamada and Satoshi Ishii. The broader team also included Real Estate Partner Maki Kawamura and Associate Ryota Hiyamizu, Finance & Projects Partner Takuya Wada, Antitrust & Competition Senior Associates Ryo Yamaguchi and Masayuki Shinoura, and IPTech Partner Tsugihiro Okada and Senior Associate Ayako Nakano. They formed part of a fully-integrated global team that included colleagues in the US such as Partners William J. Rowe, Elizabeth Barber (Chicago) and Sarah Swain (San Francisco).
“We’re honored to have supported Mitsui Chemicals, a leading Japanese company, as it takes a significant step in accelerating its global expansion in an increasingly competitive market,” noted Kiyoshi. “Baker McKenzie’s strength lies in our ability to seamlessly collaborate across the globe on complex cross-border M&A transactions like this one. We remain committed to leveraging our integrated global capabilities to support our clients’ growth strategies.”
For further details, please refer to Mitsui Chemicals’ official press release.